Scientific Fraud

Scientific fraud continues to be a great moral debate, as evidenced by articles in The Scientist and general media. Sometimes our zeal to take part in these debates hinders our resolve to find practical solutions for them. To greet with hushed shock the possibility that something may have been put into a journal that was not true is to imply that it is a rare event. Not only is it not a rare event, but it is common. Since science does not depend on every detail's being absolutely and irrevocab

Written byThomas Steffens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Since science does not depend on every detail's being absolutely and irrevocably true, we must not nitpick, or science may be inhibited. We do not know exactly how science proceeds, and if we tamper with the process, especially via arbitrary agencies outside of science, more harm than good may be done. We should marvel that objective science has progressed to the degree that it has in spite of the fact that subjective human beings are carrying it out.

Of course, the process of science will be more efficient if we minimize the amount of chaff contained in journals. This will not be accomplished by a police force checking every laboratory. Governmental overseers should get out of the business of looking at the details of science and analyze the overall structure of science as a social institution. This analysis should reveal that economic factors are responsible for more fraud than is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies